Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 RVF vaccine safety and immunogenicity study in healthy adults in Kenya
PACTR202406789723926Phase 2Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Jun 2025
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of ChAdOx1 RVF, sponsored by University of Oxford. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ChAdOx1 RVF
Beyond the preview
Go deeper on PACTR202406789723926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406789723926.